220 related articles for article (PubMed ID: 3497501)
21. The immunization of children with combined diphtheria and tetanus vaccine in Sweden.
Larsen K; Ullberg-Olsson K; Wickbom B; Hederstedt B
J Biol Stand; 1987 Apr; 15(2):103-7. PubMed ID: 3597445
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the immunological effectiveness of the planned vaccinal prophylaxis of diphtheria and tetanus in Sverdlovsk and Sverdlovsk Province].
Ivchenko SI; Basova NN; Kondrashova ZN
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):15-9. PubMed ID: 2944328
[TBL] [Abstract][Full Text] [Related]
23. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
[TBL] [Abstract][Full Text] [Related]
24. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
[No Abstract] [Full Text] [Related]
25. Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.
Simonsen O; Klaerke M; Klaerke A; Bloch AV; Hansen BR; Hald N; Hau C; Heron I
Acta Pathol Microbiol Immunol Scand C; 1986 Oct; 94(5):219-25. PubMed ID: 3565028
[TBL] [Abstract][Full Text] [Related]
26. A two-dose schedule for immunization of infants using a more concentrated DPT-vaccine.
Mangay-Angara A; Fulgencio L; Casabal G; Gudani L; Sumpaico J; Ocampo A; Nagel J; Hagenaars AM; van Hemert PA; Cohen H
Dev Biol Stand; 1978; 41():15-22. PubMed ID: 753647
[TBL] [Abstract][Full Text] [Related]
27. [The immunological effectiveness of small doses of diphtheria and tetanus anatoxins in the revaccination of children with allergy-altered reactivity and adults].
Egor'kov NA; Maksimova NM; Kostinov MP; Fedotov VA; Shchukina IA; Izotova ZB; Glebova OI; Lobanova AN
Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):47-52. PubMed ID: 2117319
[TBL] [Abstract][Full Text] [Related]
28. [Specific prevention of diphtheria in adults in foci of this infection].
Maksimova NM; Sukhorukova NL; Kostiuchenko GI; Mikhaĭlova NB; Demina DI
Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):36-40. PubMed ID: 3687294
[TBL] [Abstract][Full Text] [Related]
29. [Collective immunity to diphtheria in the children and adolescents of Vladivostok during a mass immunization against this infection].
Besednova NN; Kudrina NV; Kuznetsova TA; Zaporozhets TS; Lunika IG; Belogolovkina NA; Ivanova NIu; Voronok VM
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):82-4. PubMed ID: 9432857
[TBL] [Abstract][Full Text] [Related]
30. [The level of postvaccinal immunity to diphtheria, tetanus and poliomyelitis in relation to the number of inoculations].
Chudnaia LM; Oksiiuk VG; Shekhter AB; Krasiuk LS; Afanas'eva SM; Bryzhata SI; Kozhan NE; Chaban EP
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):46-9. PubMed ID: 1650072
[TBL] [Abstract][Full Text] [Related]
31. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis).
Lau RC
Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065
[TBL] [Abstract][Full Text] [Related]
32. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
[TBL] [Abstract][Full Text] [Related]
33. Immunity and immunization of children against tetanus in sweden.
Christenson B; Böttiger M
Scand J Infect Dis; 1991; 23(5):643-7. PubMed ID: 1767261
[TBL] [Abstract][Full Text] [Related]
34. [Effect of histamine on the rosette-forming capacity of T-lymphocytes in immunization with ADPT vaccine and its components].
Kamalova MN; Nuriddinova NR
Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):106-8. PubMed ID: 2904199
[TBL] [Abstract][Full Text] [Related]
35. [Effect of homosensitization on the immune response to ADPT vaccine].
Rusakova EV; Moshiashvili IIa
Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):113-7. PubMed ID: 6984266
[TBL] [Abstract][Full Text] [Related]
36. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
Bégué PC; Grimprel EM; Giovannangeli MD; Abitbol VI
Pediatr Infect Dis J; 1998 Sep; 17(9):804-9. PubMed ID: 9779766
[TBL] [Abstract][Full Text] [Related]
37. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.
Tran Minh NN; He Q; Ramalho A; Kaufhold A; Viljanen MK; Arvilommi H; Mertsola J
Pediatrics; 1999 Dec; 104(6):e70. PubMed ID: 10586004
[TBL] [Abstract][Full Text] [Related]
38. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
39. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes after DTP immunization.
Habig WH; Holohan TV; Phillips TM
J Pediatr; 1988 Jan; 112(1):162-3. PubMed ID: 3257263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
